Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 4Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Teratoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Polycystic Ovary Syndrome 1Ovarian Germ Cell Cancer 1Neuroblastoma 1Locally Advanced Cervical Adenocarcinoma 1Infertility 1Ganglioneuroblastoma 1Endodermal Sinus Tumor 1Carcinosarcoma 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Vaccines, Synthetic 2Radiation 2Vaccines 1Therapeutics 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Platinum 1Papillomavirus Vaccines 1Octreotide 1Fentanyl 1Dehydroepiandrosterone 1Congresses as Topic 1Cisplatin 1Brachytherapy 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Vaginal Neoplasms × Congresses as Topic × Clear all
NCT02466971 2026-04-13

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡